UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 36

Sortiert nach

Recent therapeutic advances in urothelial carcinoma: A paradigm shift in disease management

Critical reviews in oncology/hematology, 2022-06, Vol.174, p.103683-103683, Article 103683

2022

Volltextzugriff (PDF)

Exploratory analyses of treatment subgroup interaction by PD-L1 status and according to PD-L1 expression in the JAVELIN Bladder 100 trial

Clinical & translational oncology, 2024-06, Vol.26 (6), p.1532-1538

2024

Volltextzugriff (PDF)

Electrochemical reduction of HMF to synthesize added value compounds using CuAg electrodes

Electrochimica acta, 2024-01, Vol.475, p.143676, Article 143676

2024

Volltextzugriff (PDF)

Targeting oncogenic ALK: a promising strategy for cancer treatment

Molecular cancer therapeutics, 2011-04, Vol.10 (4), p.569-579

2011

Volltextzugriff (PDF)

Notch Signaling in Development and Cancer

Endocrine reviews, 2007-05, Vol.28 (3), p.339-363

2007

Volltextzugriff (PDF)

The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors

Journal of cell science, 2003-02, Vol.116 (Pt 3), p.499-511

2003

Volltextzugriff (PDF)

Experience with Sunitinib in metastatic renal cell carcinoma (mRCC) patients: pooled analysis from 3 Spanish observational prospective studies

Expert opinion on drug safety, 2018-06, Vol.17 (6), p.573-579

2018

Volltextzugriff (PDF)

Genetic profiling of epithelial cells expressing E-cadherin repressors reveals a distinct role for snail, slug, and E47 factors in epithelial-mesenchymal transition

Cancer research (Chicago, Ill.), 2006-10, Vol.66 (19), p.9543-9556

2006

Volltextzugriff (PDF)

Notch activation stimulates migration of breast cancer cells and promotes tumor growth

Breast cancer research : BCR, 2013-07, Vol.15 (4), p.R54-R54, Article R54

2013

Volltextzugriff (PDF)

Notch Signaling Is Essential for Ventricular Chamber Development

Developmental cell, 2007-03, Vol.12 (3), p.415-429

2007

Volltextzugriff (PDF)

Preclinical Test of Dacomitinib, an Irreversible EGFR Inhibitor, Confirms Its Effectiveness for Glioblastoma

Molecular cancer therapeutics, 2015-07, Vol.14 (7), p.1548-1558

2015

Volltextzugriff (PDF)

The dual kinase complex FAK-Src as a promising therapeutic target in cancer

OncoTargets and therapy, 2010-06, Vol.3 (default), p.83-97

2010

Volltextzugriff (PDF)

The transcription factors Slug and Snail act as repressors of Claudin-1 expression in epithelial cells

Biochemical journal, 2006-03, Vol.394 (Pt 2), p.449-457

2006

Volltextzugriff (PDF)

Monitoring Notch1 activity in development: Evidence for a feedback regulatory loop

Developmental dynamics, 2007-09, Vol.236 (9), p.2594-2614

2007

Volltextzugriff (PDF)

The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors

Journal of cell science, 2016-03, Vol.129 (6), p.1283-1283

2016

Volltextzugriff (PDF)

Clinical Factors Associated With Long-Term Benefit in Patients With Metastatic Renal Cell Carcinoma Treated With Axitinib: Real-World AXILONG Study

Clinical genitourinary cancer, 2022-02, Vol.20 (1), p.25-34

2022

Volltextzugriff (PDF)

Notch signalling in cancer stem cells

Clinical & translational oncology, 2009, Vol.11 (1), p.11-19

2009

Volltextzugriff (PDF)

Fructose transporter GLUT5 expression in clear renal cell carcinoma

Oncology reports, 2011-02, Vol.25 (2), p.315-323

2011

Volltextzugriff (PDF)

Biology of BMP signalling and cancer

Clinical & translational oncology, 2009-03, Vol.11 (3), p.126-137

2009

Volltextzugriff (PDF)

Glucose transporter expression and the potential role of fructose in renal cell carcinoma: A correlation with pathological parameters

Molecular medicine reports, 2010-07, Vol.3 (4), p.575-580

2010

Volltextzugriff (PDF)

Expression of Notch1 to -4 and their ligands in renal cell carcinoma: a tissue microarray study

Cancer genomics & proteomics, 2011-03, Vol.8 (2), p.93

2011

Volltextzugriff (PDF)

Fructose transporter GLUTS expression in clear renal cell carcinoma

Oncology reports, 2011, Vol.25 (2), p.315-323

2011

Volltextzugriff (PDF)

Targeting EGFR in glioblastoma: Preclinical testing of dacomitinib

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.e13015-e13015

2014

Volltextzugriff (PDF)

GEINO-11: A prospective multicenter, open label, phase II pilot clinical trial to evaluate safety and efficacy of PF-299804 (dacomitinib), a pan-HER irreversible inhibitor, in patients with recurrent glioblastoma with EGFR amplification or presence of EGFRvIII mutation

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.TPS2110-TPS2110

2014

Volltextzugriff (PDF)

Comparison of stem cell signaling pathways in long-term responders (LR) versus primary refractory (PR) patients with metastatic clear-cell renal cell carcinoma (ccRCC) under sunitinib (SU) treatment (SULONG study)

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.4578-4578

2014

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(35)
Buchkapitel
(1)

Sprache

Englisch
(36)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Recent therapeutic advances in urothelial carcinoma: A paradigm shift in disease management

Exploratory analyses of treatment subgroup interaction by PD-L1 status and according to PD-L1 expression in the JAVELIN Bladder 100 trial

Electrochemical reduction of HMF to synthesize added value compounds using CuAg electrodes

Targeting oncogenic ALK: a promising strategy for cancer treatment

Notch Signaling in Development and Cancer

The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors

Experience with Sunitinib in metastatic renal cell carcinoma (mRCC) patients: pooled analysis from 3 Spanish observational prospective studies

Genetic profiling of epithelial cells expressing E-cadherin repressors reveals a distinct role for snail, slug, and E47 factors in epithelial-mesenchymal transition

Notch activation stimulates migration of breast cancer cells and promotes tumor growth

Notch Signaling Is Essential for Ventricular Chamber Development

Preclinical Test of Dacomitinib, an Irreversible EGFR Inhibitor, Confirms Its Effectiveness for Glioblastoma

The dual kinase complex FAK-Src as a promising therapeutic target in cancer

The transcription factors Slug and Snail act as repressors of Claudin-1 expression in epithelial cells

Monitoring Notch1 activity in development: Evidence for a feedback regulatory loop

The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors

Clinical Factors Associated With Long-Term Benefit in Patients With Metastatic Renal Cell Carcinoma Treated With Axitinib: Real-World AXILONG Study

Notch signalling in cancer stem cells

Fructose transporter GLUT5 expression in clear renal cell carcinoma

Biology of BMP signalling and cancer

Glucose transporter expression and the potential role of fructose in renal cell carcinoma: A correlation with pathological parameters

Expression of Notch1 to -4 and their ligands in renal cell carcinoma: a tissue microarray study

Fructose transporter GLUTS expression in clear renal cell carcinoma

Targeting EGFR in glioblastoma: Preclinical testing of dacomitinib

GEINO-11: A prospective multicenter, open label, phase II pilot clinical trial to evaluate safety and efficacy of PF-299804 (dacomitinib), a pan-HER irreversible inhibitor, in patients with recurrent glioblastoma with EGFR amplification or presence of EGFRvIII mutation

Comparison of stem cell signaling pathways in long-term responders (LR) versus primary refractory (PR) patients with metastatic clear-cell renal cell carcinoma (ccRCC) under sunitinib (SU) treatment (SULONG study)

Suchergebnisse filtern